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One characteristic of ageing skeletal muscle is a decline inmitochondrial function. Activation of
AMP-activatedproteinkinase (AMPK)occurs in response to an increasedAMP/ATPratio,which
is one potential result ofmitochondrial dysfunction.Wehave previously observed higherAMPK
activity in old (O; 30months) vs young adult (YA; 8 months) fast-twitch muscle in response to
chronic overload. Here we tested the hypothesis that AMPK would also be hyperactivated in O
vs YA fast-twitch extensor digitorum longus muscles from Fischer344 × Brown Norway (FBN)
rats (n = 8 per group) in response to high-frequency electrical stimulation of the sciatic nerve
(HFES) or injection of AICAR, an activator of AMPK.Muscles were harvested immediately after
HFES (10 sets of six 3-s contractions, 10 s rest between contractions, 1 min rest between sets)
or 1 h after AICAR injection (1mg (g body weight)−1 subcutaneously). The phosphorylations
of AMPKα and acetyl-CoA carboxylase (ACC2; a downstream AMPK target) were both greatly
increased (P ≤ 0.05) in response to HFES inOmuscles, but were either unresponsive (AMPK α)
or much less responsive (ACC) in YA muscles. AMPK α2 activity was also greatly elevated in
response to HFES in O muscles (but not YA muscles) despite a lower total AMPK α2 protein
content in O vs YA muscles. In contrast, AMPK α2 activity was equally responsive to AICAR
treatment in both age groups. Since mitochondrial content and/or efficiency could potentially
underlie AMPK hyperactivation, wemeasured levels of mitochondrial proteins as well as citrate
synthase (CS) activity. While CS activity was increased by 25% in O vs YA muscles, uncoupling
protein-3 (UCP-3)protein levelwasupregulatedwith ageby353%.Thus,AMPKhyperactivation
in response to contractile activity in aged fast-twitch muscle may be the result of compromised
cellular energetics and not necessarily due to an inherent defect in responsiveness of the AMPK
molecule per se.
(Resubmitted 14 November 2008; accepted after revision 9 March 2009; first published online 16 March 2009)
Corresponding author D. M. Thomson: Department of Physiology and Developmental Biology, 645 WIDB, Brigham
Young University, Provo, UT 84602, USA. Email: david_thomson@byu.edu
One of the major regulators of cellular energy metabolism
is the enzyme AMP-activated protein kinase (AMPK).
AMPK is a heterotrimeric enzyme that has been described
as an intracellular ‘low-fuel warning system’ owing to the
primary mechanism by which it is activated (Hardie &
Carling, 1997). As energy-consuming processes within the
cell break down ATP, the concentration of ADP begins
to rise. Some of this ADP is used to regenerate ATP
through the adenylate kinase reaction, which converts two
ADP into one ATP and one AMP molecule. The resultant
increase in AMP concentration leads to the activation of
AMPK. This activation results both fromphosphorylation
of Thr172 on AMPK’s α subunit (without which AMPK is
essentially inactive), and also bywayof allosteric activation
of phosphorylated AMPK (Winder & Thomson, 2007).
Phosphorylation of AMPK is accomplished by several
upstream kinases. In skeletal muscle the primary
AMPK kinase is LKB1, which requires two binding
partners, mouse protein 25 (MO25) and Ste-related
adapter protein (STRAD), for full activity. Ablation
of LKB1 in skeletal muscle essentially eliminates
AMPK phosphorylation (Sakamoto et al. 2005; Koh
et al. 2006; Thomson et al. 2007a,b, 2008), although,
calcium–calmodulin-dependent protein kinase kinase
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(CaMKK) also appears to play a role in the
phosphorylation of AMPK in skeletal muscle under some
circumstances (Jensen et al. 2007; Witczak et al. 2007).
While phosphorylation at Thr172 is a requisite for its
activity, AMPK’s phosphorylation state appears to be
regulated primarily at the level of its suitability as a target
for protein phosphatase 2C (PP2C), rather than as a
function of its interaction with upstream kinases (Davies
et al. 1995; Suter et al. 2006). Additionally, AMPK activity
may be regulated by hormonal signals, and thus may
be controlled via cross-talk between signalling pathways
(Winder & Thomson, 2007).
Once activated, the general function of AMPK is to
restore the energy charge of the cell. This is accomplished
through signalling to many targets. For instance, AMPK
acutely stimulates glucose uptake (Merrill et al. 1997;
Hayashi et al. 1998) and fat oxidation (Merrill et al.
1997), while inhibiting protein synthesis (Bolster et al.
2002). When chronically activated, AMPK promotes
mitochondrial biogenesis by increasing the concentrations
of peroxisome proliferator activated receptor γ (PPARγ)
coactivator-1 (PGC-1) and associated mitochondrial
proteins (Winder et al. 2000; Bergeron et al. 2001; Suwa
et al. 2003).
ATP content and rate of ATP production under
low-energy conditions are lower in old (O) compared
to young muscles (Chen Scarabelli et al. 2008). This is
probably due to a decline in mitochondrial function
that occurs with old age in human (Tonkonogi et al.
2003; Short et al. 2005) and rodent (Mansouri et al.
2006; Figueiredo et al. 2008) skeletal muscle. The
impairment in ATP generating capacity may be due
to a decline in mitochondrial content in aged skeletal
muscle (Corsetti et al. 2008), or increased mitochondrial
uncoupling (efficiency or amount of ATP produced per
unit of oxygen consumed) observed in aged muscles,
particularly type II fibres (Conley et al. 2007a,c). Given
the mechanism by which AMPK is activated, one might
postulate that AMPK activity should therefore be elevated
in old compared to young muscles, particularly under
conditions of energy stress. In support of this hypothesis,
we previously observed that AMPK phosphorylation
was greater in fast-twitch plantaris muscles from O
vs YA rats after a week of synergist ablation-induced
overload (Thomson & Gordon, 2005). Our findings
are essentially in agreement with human data reported
by Drummond et al. (2008), which showed that vastus
lateralis AMPK phosphorylation was elevated after
resistance exercise in old, but not young individuals after
resistance exercise. However, in contrast to these findings,
Reznick et al. (2007) reported that, unlike that in young
muscles, AMPK activity in old muscles was responsive
to neither exercise training nor the AMPK activators
5′-aminoimidazole-4-carboxamide-1-β-D-ribofuranoside
(AICAR) and β-guanidinopropionic acid (β-GPA). The
authors suggested that reduced AMPK activity might
contribute to age-related impairment of mitochondrial
function. Further, Qiang et al. (2007) reported that
AMPK phosphorylation was lower in old vs young
muscles basally, but that old muscles were nonetheless
responsive to AICAR treatment. Thus, our understanding
of the effect of age on skeletal muscle AMPK activity is still
unclear. In an effort to further clarify, we studied the effect
of AICAR or muscle contraction upon AMPK activity in
YA and O extensor digitorum longus (EDL; fast-twitch)
muscles from FBN rats. Given our previous findings, we
hypothesized that AMPK would be hyperactivated in
response to both stimuli in O compared to YA muscles.
Methods
Animals and ethical approval
YA (8months; n = 8) and O (30months; n = 8) male
Fischer344 × Brown Norway (FBN) hybrid rats were used
in this study. They were housed in the East Carolina
University animal care facility at the Brody School of
Medicine on a 12 h light–dark cycle with free access to
water and standard chow. All procedures were approved
by the East Carolina University Animal Care and Use
Committee.
AICAR injection
Rats (YA and O) were injected subcutaneously with
AICAR dissolved in saline (1 mg (g body wt)−1; 75 mg
AICAR (ml saline)−1) or with an equivalent volume
of saline without AICAR. After injection, rats were
anaesthetized by isoflurane inhalation (2–4%with nitrous
oxide in supplemental oxygen) sufficient to achieve
surgical anaesthetic depth. Fifty minutes after AICAR or
saline injection, ketamine (11.25 mg (100 g body wt)−1)
and xylazine (1.25mg (100 g body wt)−1) were injected
intraperitoneally. This was done to facilitate the removal
of tissues by eliminating the need for administering
vapourized anaesthetic through a nose-cone. Ten minutes
after this injection, tibialis anterior (TA) and EDLmuscles
were removed from the hindlimbs, frozen between metal
tongs cooled to the temperature of liquid nitrogen, and
frozen at −80◦C until later analysis. Thus, the rats were
anaesthetized for 1 h prior to the removal of tissues,
allowing substantial time for AMPK activity to equilibrate
to true resting levels.
Electrical stimulation of sciatic nerve
After anaesthesia with isoflurane, the sciatic nerve of
the left hindlimb of saline-injected rats was isolated
just proximal to the point of trifurcation. Stainless steel
electrodes were attached, and a HFES electrical
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stimulation bout was elicited using a Grass Stimulator
(100 Hz; Grass Model S48 Stimulator, Quincy, MA,
USA). The bout consisted of 10 sets of six maximal
contractions (3 s duration with 10 s rest between
contractions) of the hindlimb musculature, with 1min
rest periods between sets, for a total contraction
bout of about 22min. The contralateral (right)
hindlimb was not subjected to the operation or electrical
stimulation. Timing of the contraction bout was such that
it ended 1 h after saline injection. Ketamine–xylazine was
administered 10min prior to the end of stimulation, after
which TA and EDL muscles were removed immediately
(within 1–3min) after cessation of contractions (60min
after saline injection) and harvested as described above.
Homogenization
Muscles were ground-glass homogenized in 20 volumes of
homogenization buffer (50mM tris-HCl, pH 7.4; 250mM
mannitol; 50 mMNaF; 5 mM sodium pyrophosphate;
1 mM EDTA; 1mM EGTA; 1% Triton X-100; 50mM
β-glycerophosphate; 1 mM sodium orthovanadate; 1 mM
DTT; 1mMbenzamidine; 0.1 mMphenylmethane sulfonyl
fluoride; 5μgml−1 soybean trypsin inhibitor). A portion
of the raw EDL homogenate was separated for citrate
synthase activity determination. The remaining raw
homogenate was centrifuged at 800 g . The clarified
supernatant was separated into a fresh tube, and the pellet
was then centrifuged at 10 000 g , and this supernatant was
combined with the previous one. Homogenates were then
analysed for protein content using the DC Protein Assay
(Biorad Laboratories, Hercules, CA, USA).
Citrate synthase activity assay
Citrate synthase activity wasmeasured fromdilutedwhole
EDL muscle homogenates as described by Srere (1969).
Glycogen concentration assay
Glycogen concentration was determined in TA muscles
(n = 6 per group) as previously described (Passonneau &
Lowry, 1993).
AMPK activity assay
AMPKactivity ofα1 andα2 subunits immunoprecipitated
from EDL homogenates towards SAMS peptide
was assessed and expressed as picomoles phosphate
incorporated intoHHMRSAMSGLHLVKRR-OH(SAMS)
peptide per gram tissue per minute, as described
previously (Park et al. 2002). Due to a lack of adequate
tissue for all muscles, this assay was only performed on six
samples per condition.
Western blotting
Clarified muscle homogenates were diluted in 2×
loading buffer at a concentration of 1μgμl−1. Equal
amounts of protein were separated via SDS-PAGE then
transferred to PVDF membranes, which were then
stained with Ponceau S, and examined for equal protein
loading and transfer. Membranes were then washed with
tris-buffered saline+ 0.1% tween (TBST), and blocked
using 5% non-fat dry milk (NFDM) in TBST. Membranes
were washed briefly with TBST and then incubated over-
night on a shaker at 4◦C with primary antibody diluted
in 1% BSA, pH 7.6. Primary antibody dilutions were as
follows: phospho-AMPK α (Cell Signalling Technology
no. 2531, Beverly, MA, USA), 1 : 4000; total AMPK α
(Cell Signalling no. 2532), 1 : 5000; AMPK α1 and α2
(custom made through Affinity Bioreagents, Golden,
CO, USA), 1 : 50 000; phospho-ACC (Cell Signalling no.
3661), 1 : 4000; total ACC (streptavidin-HRP, GE Life
Sciences, RPN1231), 1 : 20 000; LKB1 (Upstate no. 07-694,
Lake Placid, NY, USA), 1 : 5000; PGC-1 (Calbiochem no.
516557, La Jolla, CA,USA), 1 : 2000; cytochrome c oxidase
subunit 1 (COX-1; Invitrogen no. A6403, Carlsbad, CA,
USA), 1 : 4000; cytochrome C (Santa Cruz no. 13156),
1 : 10 000; UCP-2 (Millipore no. AB3226, Temecula, CA,
USA), 1 : 1000; UCP-3 (Affinity Bioreagents no. PA1-055,
Golden, CO, USA), 1 : 2000.
Statistics
Statistical comparisons were made by either a 1-way or
2-way ANOVA, using NCSS statistical analysis software
(NCSS, Kaysville, UT, USA). Data are presented as
means± standard error of the mean (S.E.M.). Statistical
significance was set at P ≤ 0.05.
Results
AMPK activity
In vitro activity of the AMPK α1 subunit was higher in
O vs YA muscles regardless of treatment, and increased
with AICAR, but not HFES, in YA but not O muscles
(Fig. 1A). In controlmuscles, in vitro activity of the AMPK
α2 subunit was not different between ages, and increased
inbothYAandOmuscles afterAICARtreatment (Fig. 1B).
HFES, on the other hand, failed to activate AMPK α2
in YA muscles, but significantly increased activity by
220% in O muscles (Fig. 1B). AMPK phosphorylation
at Thr172 closely corresponded to the in vitro activity
data for AMPK α2 (Fig. 1C). Phosphorylation of ACC2,
representing in vivo activity of AMPK (Park et al. 2002),
was also similar to AMPK α2 in vitro activity, except that
it was significantly increased by HFES in YA muscles.
Nevertheless, this increase was significantly less than in
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O muscles (Fig. 1D). Also, the relative increase in ACC2
phosphorylation was similar between ages after AICAR
treatment, suggesting that in vivo AICAR-stimulated
AMPK activity toward ACC is not different with age.
Protein concentrations for AMPK and LKB1
AMPK α1 protein concentration was 120% greater in O
vs YA muscles (Fig. 2A). Conversely, AMPK α2 protein
concentration in O muscles was only 75% of that in
YA muscles (Fig. 2B). Protein levels of LKB1, the major
upstream kinase for AMPK in skeletal muscle, were not
different between ages (Fig. 2C).
Mitochondrial protein concentrations
Protein concentrations for PGC1α (a key factor in
the regulation of mitochondrial biogenesis) as well as
Figure 1. AMPK activation in extensor digitorum longus muscles from young adult (8 months) and old
(30 months) rats after AICAR treatment and high-frequency electrical stimulation (HFES)
Rats were injected with 1 mg (g body wt)−1 AICAR or an equivalent volume of saline (control and HFES). Contrac-
tions were induced by HFES of the sciatic nerve. Muscles were harvested 1 h after saline or AICAR treatment, and
immediately post-HFES. A, incorporation of radiolabelled phosphate into SAMS peptide by immunoprecipitated
AMPK α1 (n = 6). B, incorporation of radiolabelled phosphate into SAMS peptide by immunoprecipitated AMPK
α2 (n = 6). C, AMPK (α1 and α2) phosphorylation (n = 8). D, phosphorylation of the AMPK substrate acetyl-CoA.
carboxylase (ACC)-2 (n = 8). YA, young adult; O, old; C, control (saline treated); A, AICAR treated; H, HFES treated.
∗Significant difference (P < 0.05) vs corresponding saline-treated control muscles within age group. #Significant
difference vs corresponding young adult muscles.
cytochrome C and UCP-2 (a mitochondrial protein) were
not significantly different between O and YA muscles
(Fig. 3A, B andD). On the other hand, COX-1 and UCP-3
concentrations, as well as citrate synthase activity, were
significantly greater in O vs YAmuscles (181%, 353% and
25% higher vs YA, respectively; Fig. 3C, E and F).
Glycogen concentration
The ANOVA analysis indicated that glycogen
concentration declined significantly (main effect)
with HFES in TA muscles (31.8± 1.6 vs 28.3± 2.0μmol
(g muscle)−1 in YA and 36.1± 3.1 vs 25.6± 2.8μmol
(g muscle)−1 in O). This main effect of HFES in the
two-way ANOVA was obviously due in large part to
the decline in glycogen concentration in O muscle;
subsequent one-way ANOVAs within each age group
indicated a significant glycogen decrease in O (P = 0.03)
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Figure 2. AMPK and LKB1 protein
concentrations in extensor digitorum
longus muscles from young adult
(8 months) and old (30 months) rats
A, AMPK α1 protein concentration (n = 8).
B, AMPK α-2 concentration (n = 8). C, LKB1
protein concentration (n = 8). YA, young adult
(8 months); O, old (30 months). ∗Significant
difference vs young adult (P < 0.05).
Figure 3. PGC-1 and mitochondrial protein concentrations in extensor digitorum longus muscles from
young adult (8 months) and old (30 months) rats
A, PGC-1α protein concentration (n = 8). B, cytochrome C concentration (n = 8). C, COX-1 protein concentration
(n = 8). D, UCP-2 protein concentration (n = 8). E, UCP-3 protein concentration (n = 8). F, citrate synthase activity
(n = 8). YA, young adult (8 months); O, old (30 months). ∗Significant difference vs young adult (P < 0.05).
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but not YA (P = 0.20) muscles with HFES. Furthermore,
when expressed as percentage decline in glycogen in HFES
vs contralateral control muscles from the same animal,
glycogen depletion was 3-fold greater after contraction
in O (28.7± 5.5% decline) vs YA (9.6± 9.2% decline)
muscles.
Discussion
The primary finding of this study is that HFES-induced
muscle contractions activate AMPK to a much greater
extent in O than in YA skeletal muscle from FBN hybrid
rats, and that this AMPK hyperactivation in O muscles
is specific to the α2 subunit. In contrast, there were
no differences with age in the AICAR-induced AMPK
response. The HFES contraction bout employed here
was designed to simulate vigorous resistance exercise.
As such, when it is repeated chronically it promotes
activation of signalling pathways that promote hyper-
trophy within the muscle (Baar & Esser, 1999). However,
it is ineffective at activating AMPK, at least covalently, in
YA muscle, probably due to the relatively abundant rest
periods included as compared with other
AMPK-activating contraction protocols (Hutber
et al. 1997; Vavvas et al. 1997; Hayashi et al. 1998). When
applied in vitro, a similar intermittent HFES contraction
protocol also failed to activate AMPK in muscles from
YA rats whereas continuous low-frequency stimulation
strongly activated AMPK (Atherton et al. 2005). The
intermittent rest periods during HFES probably prevent
an appreciable accumulation of AMP during the bout in
YA muscles, thereby preventing activation of AMPK.
In contrast to YA, O muscles exhibited an accentuated
and robust AMPK α2 response to HFES. This result could
not have been due to elevated α2 protein content, as
this was lower in the O compared with YA muscles.
Furthermore, the enhanced activation of AMPK in O
muscle cannot be attributed to an increased concentration
of LKB1 (the major upstream AMPK kinase (AMPKK) in
skeletal muscle (Sakamoto et al. 2005; Koh et al. 2006;
Thomson et al. 2007b)), because it was equal between
ages. Also, previous reports (Suter et al. 2006; Sanders
et al. 2007) indicate that its activity towards AMPK is
constitutive and not regulated directly by phosphorylation
or other knownmeans. Thus, assuming that the AMPK α2
hyperactivation in O muscles after contractions is due to
the classic activatingmechanismof an increasedAMP/ATP
ratio, one possibility is that it occurred because of an
inability to sufficiently replenish ATP during the rest
periods between contractions, which could suggest a
mitochondrial insufficiency.
Although cytochrome C content was not different
between ages, we did observe 25% greater activity for
citrate synthase in EDL muscles from O vs YA rats,
which agrees with some previously reported findings
(Sanchez et al. 1983; Masuda et al. 2008). Likewise,
COX-1 protein content was elevated by 180% in O vs YA
EDL. Moreover, by far the most pronounced difference
in mitochondrial protein content that we observed was
the 353% higher skeletal EDL muscle UCP-3 content in
O compared to YA EDL. While the functional role of
UCP-3 in skeletal muscle is controversial (Bezaire et al.
2007), if present in sufficient quantity above normal levels,
it can act as an uncoupling protein, thereby decreasing
mitochondrial efficiency (ATP produced/O2 consumed).
For example, overexpression of UCP-3 in cells and
transgenic mice leads to mitochondrial uncoupling
(Clapham et al. 2000; Cadenas et al. 2002). Likewise,
decreased proton leak and increased mitochondrial
coupling (Gong et al. 2000; Vidal-Puig et al. 2000), as well
as increased rate of fastingATP synthesis (Cline et al. 2001)
havebeen reported inUCP-3knockoutmice, although this
is not a consistent finding (Cadenas et al. 2002). Induction
of mild UCP-3-mediated uncoupling via superoxide has
also been demonstrated in skeletal muscle mitochondria
(Echtay et al.2002),which is important in regards to ageing
because reactive oxygen species production is elevated
in aged skeletal muscle (Chabi et al. 2008). Whether
or not the increased UCP-3 protein concentration in
aged muscle that we have reported here is sufficient to
cause significant uncoupling is not known; however, mild
uncoupling has been observed in aged human (Amara
et al. 2007) and rodent (Marcinek et al. 2005) skeletal
muscle, which, along with generalized mitochondrial
dysfunction, are indicative of a potential mechanism
that may drive the hyperactivation of AMPK under
conditions of energy stress. That is, as the energy demand
of the muscle fibre is increased, such mitochondrial
dysfunction and/or uncoupling could certainly limit the
ATP-generating capacity of the fibre in aged muscle,
thus leading to activation of AMPK under circumstances
that normally would not strain the energy-generating
machinery. In the case of the present study, uncoupling of
oxidative phosphorylation may result in a mitochondrial
inefficiency that would negatively impact on the ability of
the cell to recover from the energy stress of the contraction
bout. It must be emphasized, however, that this hypo-
thesized relationship between UCP-3 levels and AMPK
hyperactivation is based only upon the correlational data
presented above, and will therefore need to be confirmed
through further experimentation.
Another potential factor that may have contributed to
the contraction-induced AMPK hyperactivation that we
observed in O muscles is glycogen concentration. High
glycogen has been shown to inhibit AMPK activation
in skeletal muscle (Derave et al. 2000; Wojtaszewski
et al. 2002). Although we were unable to assess glycogen
concentration in the EDL muscles from our rats due to a
lack of tissue, we did measure it in a limited number of
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tibialis anterior (TA) muscles from the same animals. Like
the EDL, the TA contracts in opposition to the gastro-
cnemius muscle when the sciatic nerve is stimulated.
Accordingly, ACC phosphorylation in the TA responded
similarly to that in the EDL after contraction, and UCP-3
levels were similarly elevated with age (data not shown).
Although glycogen concentration significantly declined
in both YA and O TA muscles after contraction (main
effect), this statistical effect was probably driven primarily
by the glycogen decline in O muscles which was 3 times
greater than the decline in YA muscles. Although this
age-related difference was not statistically significant in
our study (P = 0.09; probably due to the limited number
of TAmuscles available for analysis) previous reports have
also shown greater glycogen depletion in Omuscle during
contraction compared to YA (Cartee, 1994; Hopp, 1996).
If glycogen levels did indeed decline in the EDL as they
appear to have done in the TA muscle, this could explain,
at least in part, the enhanced activation of AMPK that we
observed in the O EDL muscles.
Reznick et al. have reported that AMPK activation was
completely impaired in old Fischer344 rats in response to
aerobic exercise, AICAR and β-GPA feeding, and that
β-GPA failed to stimulate mitochondrial biogenesis in
their old rats (Reznick et al.2007). Thiswould theoretically
indicate that AMPK is somehow unresponsive to stimuli
in agedmuscle; however, the present investigationpresents
evidence in strong opposition to the notion of impaired
contraction-induced AMPK activation with age, at least
in response to HFES. Moreover, we have also previously
shown a similar AMPK hyperactivation in aged muscle
in response to the increased activity of chronic overload
(Thomson & Gordon, 2005). The fact that our present
data show no age-related difference in AICAR-stimulated
AMPK activity (i.e. in response to an AMP analogue that
does not disturb cellular energetics (Corton et al. 1995))
indicates that there may be no age-related dysfunction
in the AMPK molecule per se. Similarly, Qiang and
co-workers also showed that AMPK phosphorylation
in old muscle increases in response to AICAR (Qiang
et al. 2007). Since AICAR-stimulated AMPK activity is
independent of the effect of cellular bioenergetics, our
data collectively indicate that AMPK hyperactivation in
response to contractile activity in aged fast-twitch muscle
probably results from upstream bioenergetic impairments
such as mitochondrial dysfunction.
The findings of Reznick et al. (2007) also contrast
with findings in human muscle in which AMPK
hyperphosphorylation was observed after a strength
training bout (Drummond et al. 2008). Furthermore,
exercise-induced improvements in mitochondrial
function and content similar to those in young
individuals have been observed with exercise in
the elderly (Conley et al. 2007b). These studies
suggest that the exercise training-stimulated signalling
mechanisms promoting mitochondrial biogenesis are
intact in old muscles, and argue against a cross-species
generalized defect in AMPK signalling with age. Our
findings are likewise in opposition to the notion of
impaired contraction-induced AMPK activation with
age.
The conflicting findings mentioned above may be due
to a number of factors, but prominent amongst them
is the difference in strain or species studied. Reznick
et al. (2007) used the Fischer344 strain in their study,
which is commonly used in ageing studies, but may
not be the rodent model that is most representative of
ageing human muscle. In our study, which agreed more
closely with the human study of Drummond et al. (2008),
Fischer344 × Brown Norway hybrid (FBN) rats were used.
This strain of rat is considered by some to be a preferable
ageingmodel compared to the Fischer344 strain formuscle
studies because of the relatively low incidence of diseases
with age (Lipman et al. 1996). Such pathological disorders
could result in observed differences between young and
old animals being erroneously attributed to the ageing
process that in truth result from the presence of disease.
Furthermore, FBN rats exhibit an ageing process that is
more similar to that in human muscle in terms of loss
of muscle function and mass (Rice et al. 2005, 2008). In
regards to the lack of exercise-induced AMPK activation
observed by Reznick et al. (2007), several methodological
factorsmay also have contributed to the conflicting results.
In that study, treadmill running was used, and running
speed was normalized to 85% of maximum capacity for
botholdandyoung rats. Sincemaximal runningcapacity is
lower for old than for young rats, the old rats ran at nearly
half the speed of the young rats. Since exercise capacity
could be affected by cardiovascular or neurological factors
extrinsic to skeletal muscle, the metabolic stimulus for
AMPK activation may have been different between ages
for that treadmill running bout. Additionally, the rats were
trained for 4 days after the determination of maximum
running capacity and prior to the experimental exercise
bout. It is known that exercise training diminishes the
AMPK response to a subsequent exercise bout (Durante
et al. 2002), but whether this phenomenon begins within
four training bouts or is affected by ageing is unknown.
Therefore, the training prior to the exercise boutmay have
been another confounding factor. Finally, the possibility
that activation of AMPK by aerobic-type muscle activity
such as treadmill running is affected by ageing differently
than intermittent resistance-type exercise such as that used
in this study and that by Drummond et al. (2008) cannot
be discounted.
AMPKα1activitywas elevated inO vsYAmuscles across
treatments. AICAR treatment in YA muscles activated
AMPK α1 to a similar level seen in saline-treated O
muscles, while AMPK α1 activity in O muscles did not
increase. We cannot say definitively whether the lack of
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AICAR-stimulated activation in the O muscles is due to
a defect in α1 signalling, or simply because basal levels
of α1 activity are already elevated to a near-maximal
level. Regardless, the importance and role of α1 AMPK
complexes in skeletal muscle is not currently well
understood, and AMPK α2 activity and responsiveness to
exercise is much greater than that of AMPK α1 (Durante
et al. 2002).
In conclusion, we observed that AMPK was activated
in O, but not YA fast-twitch skeletal muscle in response
to a bout of electrically stimulated muscle contractions
designed to mimic resistance exercise. We also observed
similar AICAR-stimulated activation of AMPK in O
compared to YA muscles. Our findings demonstrate that
AMPKactivation in response toHFES in theEDLmuscle is
not defective with age in FBN rats. The disproportionately
elevated content of UCP-3 protein relative to other
mitochondrial proteins in O EDL muscles suggests that
mitochondrial inefficiency may potentially lie upstream
of AMPK hyperactivation in response to HFES contrac-
tions in aged muscle. Our findings are in contrast to data
previously collected from other rat strains, which
illustrates the importance of taking species and potential
strain differences into account when interpreting
age-related data.
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